Wedbush Securities Inc Entera Bio Ltd. Transaction History

Wedbush Securities Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$1.03 - $1.24 $125,264 - $150,803	-121,616 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$1.05 - $2.2 $96,188 - $201,537	91,608 Added 305.28%	121,616 $151,000
Q2 2020 Jul 16, 2020	BUY	$1.71 - $3.01 $51,313 - $90,324	30,008 New	30,008 $55,000

5.34M

2.6K

100

Ticker ENTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,809,900
Market Cap $65.1M
Description
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.